Society consensus statements and guidelines 2729 have subsequently integrated SGLT-2i and GLP-1RA under the umbrella term of glucose-lowering drugs with cardiovascular benefit and recommended their use in patients with T2D at high cardiovascular risk
Rohm TV, Meier DT, Olefsky JM, Donath MY (2022) Inflammation in obesity, diabetes and related Disorders
A.XuF.LashL
That could shift
How do I stay on track when Im traveling while on GLP-1 Travel can easily disrupt your routine, making meals, nutrition, and GLP-1 dosing less consistent and potentially increasing side effects
Gastrointestinal: acute pancreatitis, hemorrhagic and necrotizing pancreatitis sometimes resulting in death, ileus, intestinal obstruction, severe constipation including fecal impaction Hypersensitivity: anaphylaxis, angioedema Pulmonary: Pulmonary aspiration has occurred in patients receiving GLP-1 receptor agonists undergoing elective surgeries or procedures requiring general anesthesia or deep sedation